11![CHELAN‐DOUGLAS PUBLIC HEALTH http://www.cdhd.wa.gov March 2013 CHELAN‐DOUGLAS PUBLIC HEALTH http://www.cdhd.wa.gov March 2013](https://www.pdfsearch.io/img/fa02352f401cdfb0ed3e70cbbb25b97a.jpg) | Add to Reading ListSource URL: www.cdhd.wa.govLanguage: English - Date: 2013-05-02 17:25:31
|
---|
12![Pali Momi Medical Center Antimicrobial Stewardship Program Antimicrobials under review Ciprofloxacin (Cipro®) Clindamycin (Cleocin®) Daptomycin (Cubicin®) Doripenem (Doribax®) Pali Momi Medical Center Antimicrobial Stewardship Program Antimicrobials under review Ciprofloxacin (Cipro®) Clindamycin (Cleocin®) Daptomycin (Cubicin®) Doripenem (Doribax®)](https://www.pdfsearch.io/img/327648409587cf3f21e06077ba190ece.jpg) | Add to Reading ListSource URL: health.hawaii.govLanguage: English - Date: 2014-07-25 22:26:50
|
---|
13![Dear Healthcare Professional Letter Janssen Jan[removed] Dear Healthcare Professional Letter Janssen Jan[removed]](https://www.pdfsearch.io/img/f7423c5c2f4a995463084d21b05a8531.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
14![C2[removed]Activity of Doripenem (DOR) Against Molecularly Characterized AmpC and ESBL Producing Escherichia coli (EC) Including Strains with Reduced Susceptibility to Carbapenems (CRS) from Canadian Hospitals: CANWARD 200 C2[removed]Activity of Doripenem (DOR) Against Molecularly Characterized AmpC and ESBL Producing Escherichia coli (EC) Including Strains with Reduced Susceptibility to Carbapenems (CRS) from Canadian Hospitals: CANWARD 200](https://www.pdfsearch.io/img/6e7b50acd3680a2aee134b19cebfbb1f.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
15![CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE Doripenem Doripenem is a new carbapenem similar to meropenem and imipenem but different than ertapenem. Doripenem, CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE Doripenem Doripenem is a new carbapenem similar to meropenem and imipenem but different than ertapenem. Doripenem,](https://www.pdfsearch.io/img/f0cbadc02fed7df63ffe6941213265a2.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
16![E[removed]Activity of Doripenem and Other Carbapenems against 23,243 Pathogens Isolated from Canadian Hospitals: CANWARD[removed]Nancy Laing Health Sciences Centre E[removed]Activity of Doripenem and Other Carbapenems against 23,243 Pathogens Isolated from Canadian Hospitals: CANWARD[removed]Nancy Laing Health Sciences Centre](https://www.pdfsearch.io/img/f48de47f44d49de5ee3d2cff13f63457.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
17![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DORIBAX® safely and effectively. See full prescribing information for HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DORIBAX® safely and effectively. See full prescribing information for](https://www.pdfsearch.io/img/5ab73a26f5f968805aaf509d69e39686.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-01-22 15:50:20
|
---|
18![Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Doripenem for Injection for the Treatment of Nosocomial Pneumonia Meeting of Anti-Infective Drugs Advisory Committee Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Doripenem for Injection for the Treatment of Nosocomial Pneumonia Meeting of Anti-Infective Drugs Advisory Committee](https://www.pdfsearch.io/img/49d030451724000baba1f3a017b3b485.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2008-07-14 09:00:10
|
---|